Barclays CEO says he has cancer but will continue to run the bank

The CEO of Barclays mentioned Monday that he has been recognized with most cancers.

C.S. Venkatakrishnan, who is named Venkat on the financial institution, mentioned in a word to colleagues that he’ll start present process remedy for Non-Hodgkin lymphoma at Memorial Sloan Kettering Cancer Center in New York.

“The good news is that the matter has been detected early, with scans and biopsies confirming it to be very localized,” he mentioned. “The doctors have advised that my prognosis is excellent, and my condition is curable with their prescribed regimen.”

Non-Hodgkin lymphoma is a sort of most cancers that begins within the lymphatic system, weakening the immune system. According to the Mayo Clinic, it’s commonest in folks aged 60 or over, and medical advances have helped enhance the prognosis.

Venkatakrishnan mentioned his remedy is anticipated to final between 12 and 16 weeks.

During that point, the CEO mentioned the financial institution “will run normally” and he’ll stay “actively engaged in managing it,” although he’ll at instances must earn a living from home and will be unable to journey.

Venkatakrishnan has held the highest job at Barclays for one 12 months, taking up after the resignation of predecessor Jes Staley.

He beforehand served because the financial institution’s head of worldwide markets and chief threat officer. Before becoming a member of Barclays in 2016, Venkatakrishnan labored in asset administration and as an funding banker at JPMorgan Chase.

He’s not the primary CEO of a significant financial institution to be handled for most cancers whereas juggling a demanding function. Jamie Dimon, JPMorgan’s longtime chief, was recognized with throat most cancers in 2014. He additionally acquired remedy at Memorial Sloan Kettering and continued to work whereas present process about eight weeks of chemotherapy and radiation.

Shares of Barclays had been little modified in London on Monday.